Abstract
Hepatocyte growth factor (HGF) has been shown to have multiple effects on the wound healing process. Several in vitro and ex vivo models using HGF have been shown to promote wound healing. The expression of HGF and its receptor cMet are different in chronic and acute wounds. HGF treatments in chronic wounds have not lived up to the expectations of the in vitro and ex vivo models. This review looks at the different expression of the HGF receptor and HGF agonists in chronic wounds compared to acute wounds. This aberrant expression may have a value in identifying early the wounds at risk of becoming chronic. A greater understanding of HGF and HGF agonists expression will have a direct implication for a protein engineering approach to the management of chronic wounds.
Keywords: HGF, HGF agonists, c-Met, wound healing, Matriptase, Keratinocyte, proteolytic
Current Signal Transduction Therapy
Title: HGF and HGF Agonists, Expression in Wound and Potential Role in the Management of Wound Healing
Volume: 6 Issue: 2
Author(s): Kevin Conway
Affiliation:
Keywords: HGF, HGF agonists, c-Met, wound healing, Matriptase, Keratinocyte, proteolytic
Abstract: Hepatocyte growth factor (HGF) has been shown to have multiple effects on the wound healing process. Several in vitro and ex vivo models using HGF have been shown to promote wound healing. The expression of HGF and its receptor cMet are different in chronic and acute wounds. HGF treatments in chronic wounds have not lived up to the expectations of the in vitro and ex vivo models. This review looks at the different expression of the HGF receptor and HGF agonists in chronic wounds compared to acute wounds. This aberrant expression may have a value in identifying early the wounds at risk of becoming chronic. A greater understanding of HGF and HGF agonists expression will have a direct implication for a protein engineering approach to the management of chronic wounds.
Export Options
About this article
Cite this article as:
Conway Kevin, HGF and HGF Agonists, Expression in Wound and Potential Role in the Management of Wound Healing, Current Signal Transduction Therapy 2011; 6 (2) . https://dx.doi.org/10.2174/157436211795659919
DOI https://dx.doi.org/10.2174/157436211795659919 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Yeast-Derived β-Glucan in Combination with Anti-Tumor Monoclonal Antibody Therapy in Cancer
Recent Patents on Anti-Cancer Drug Discovery The Efficacy and Safety of Additional Anti-HER2-Targeting Drugs in the Treatment of HER2-Positive Advanced Breast Cancer: A Meta-Analysis
Anti-Cancer Agents in Medicinal Chemistry Molecular Imaging in Optical Coherence Tomography
Current Molecular Imaging (Discontinued) Muscarinic Receptors as Targets for Metronomic Therapy in Breast Cancer
Current Pharmaceutical Design Computational Analysis of the Interaction between Ligand-Receptor Pairs
Current Pharmaceutical Design Antibody-Drug Conjugate Targets
Current Cancer Drug Targets Aurones as New Porcine Pancreatic α-Amylase Inhibitors
Letters in Drug Design & Discovery Genetic Variation at the Human MGMT Locus and its Biological Consequences
Current Pharmacogenomics Targeting the Epidermal Growth Factor Receptor Family in Radionuclide Therapy of Tumors – Signal Transduction and DNA Repair
Letters in Drug Design & Discovery Peptides or Small Molecules? Different Approaches to Develop More Effective CDK Inhibitors
Current Medicinal Chemistry Immunoglobulin G Expression and its Potential Role in Primary and Metastatic Breast Cancers
Current Molecular Medicine Role of Chitosan Biomaterials in Drug Delivery Systems: A Patent Perspective
Recent Patents on Materials Science The Ubiquitin-Proteasome System (UPS) and the Mechanism of Action of Bortezomib
Current Pharmaceutical Design The cytotoxic effect of GW843682X on nasopharyngeal carcinoma
Anti-Cancer Agents in Medicinal Chemistry Drug Targets to Pro-Angiogenetic Factors with Special Reference to Primary Peritoneal Mesothelioma
Endocrine, Metabolic & Immune Disorders - Drug Targets Extraction, Processing, and Stabilization of Health-Promoting Fish Oils
Recent Patents on Food, Nutrition & Agriculture Circulating Advanced Oxidation Protein Products as Oxidative Stress Biomarkers and Progression Mediators in Pathological Conditions Related to Inflammation and Immune Dysregulation
Current Medicinal Chemistry Probiotics and Oral Health
Current Pharmaceutical Design Trabectedin as a New Chemotherapy Option in the Treatment of Relapsed Platinum Sensitive Ovarian Cancer
Current Pharmaceutical Design Mesenchymal stem cell therapy for inflammatory bowel diseases: promise and challenge
Current Stem Cell Research & Therapy